SOLICITATION NOTICE
A -- Systematic Review of Neonatal Medicine
- Notice Date
- 3/9/2011
- Notice Type
- Presolicitation
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Child Health and Human Development, Contracts Management Branch, 6100 Executive Blvd., Suite 7A07, MSC7510, Bethesda, Maryland, 20892-7510
- ZIP Code
- 20892-7510
- Solicitation Number
- NIH-NICHD-CDBPM-2011-2
- Point of Contact
- Adelola Kellum, Phone: 3014356955
- E-Mail Address
-
kelluml@mail.nih.gov
(kelluml@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) has a requirement for a contract to provide high quality systematic reviews and meta-analyses on published reports on diagnostic tests, medical and surgical treatment interventions in the neonatal-perinatal medicine, and provide the individual reports in a specified electronic format to the NICHD for posting on its public website. The electronic manuscript with summary evidence is made available on the NICHD website to help pediatricians across USA to access it freely, guiding their practice. Individual researchers who conduct clinical trials to evaluate the benefits of new drugs, diagnostic tests, specific therapies, or surgical interventions, etc., publish their results in peer-reviewed journals (e.g, in the New England Journal of Medicine, or JAMA, etc). When many research groups conduct research on specific interventions, their findings may or may not be the same as those of previously published research. This can lead to difficulties for choosing appropriate therapy for the practitioner. As an example: if 4 studies testing the effect of an antibiotic for sore throat conclude that the drug was not effective, 2 others concluding that was extremely effect, and 5 others studies find drug can actually worsened the disease, the clinicians cannot determine whether to use the drug or not. Thus, such contradictory outcomes need to be resolved to clarify the direction of the "collective evidence" for doctors to offer most appropriate therapy to their patients. The anticipated contract type will be a cost reimbursement a base year of one year with four option years. The RFP is anticipated to be posted on or about March 23, 2011 on FedBizOpps (FBO) website: http://www.fedbizopps.gov. Information in the anticipated RFP supersedes any information in this pre-solicitation announcement. This acquisition has been designated as full and open competition under the North American Industry Classification System (NAICS) 541712 in the North American Industry Classification System (NAICS) and the size standard for such requirements is 500 employees. Any questions concerning this announcement must be submitted in writing to Lola Kellum, Contracting Officer at lk202p@nih.gov or addressed to, NICHD Contracts Management Branch, Office of Acquisitions, NICHD, NIH, 6100 Executive Boulevard, Room 7A-07, MSC 7510, Bethesda, Maryland 20892-7510 (if hand-delivered or sending by delivery service--6100 Executive Boulevard, Suite 7A-07, Rockville, Maryland 20852). No collect calls will be accepted. This is not an RFP and this announcement does not commit the Government to award a contract. The reference number to be used for this announcement is: RFP NIH-NICHD-CDBPM-2011-02. All correspondence must cite the reference number as provided.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NICHD/NIH-NICHD-CDBPM-2011-2/listing.html)
- Record
- SN02396582-W 20110311/110309234255-6b4e5291fbfc29f09f85e52cb7ff7976 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |